Table 2_Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer.csv

Table 2_Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer.csv

Background<p>Oxaliplatin-based neoadjuvant chemotherapy (NAC) is the standard treatment for advanced colorectal cancer (CRC), yet resistance to NAC poses a significant clinical challenge.</p>Methods<p>To investigate the mechanisms of chemoresistance, we analyzed single-cell RNA seq...

Full description

Saved in:
Bibliographic Details
Main Author: Meiling Gao (6175109) (author)
Other Authors: Jiahao Qian (21717053) (author), Ping Xia (220386) (author), Wancheng Liu (7213538) (author), Yunjia Jiang (18806562) (author), Yuchang Xia (21717056) (author), Xin Yao (130614) (author), Qingqing Jiao (7496864) (author), Minggang Wei (13014378) (author)
Published: 2025
Subjects:
Genetic Immunology
colorectal cancer
oxaliplatin resistance
KLF5
GDC-0941
neoadjuvant chemotherapy
PI3K/Akt pathway
chemoresistance
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items